Evivo Corporate News

Landmark Study to Address Global Malnutrition and Restorative Effect of Infant Probiotic

Evivo is on a mission to help improve gut health for babies all over the world. We're thrilled to announce that our parent company, Evolve BioSystems, is partnering with the International Centre for Diarrhoeal Disease Research in Bangladesh to study the use of Evivo in severely malnourished babies.

Evivo Gains Health Canada Approval, Providing First International Expansion Opportunity

DAVIS, Calif., Oct. 30, 2017 (GLOBE NEWSWIRE) -- Evolve BioSystems, Inc., a microbiome company developing novel solutions to resolve infant gut dysbiosis, is pleased to announce that Evivo™ (activated B. infantis EVC001, ActiBif®) has now been granted regulatory approval for sale in Canada.

Evivo Survey Identifies Moms' Misperceptions About Breast Milk and Baby Gut Microbiome

U.S. Moms Know There's a Connection Between Breast Milk and the Infant Gut, But Most Don't Know Up To 15% of Breast Milk Nutrients Are Wasted Yet Critical During First Six Months.

Evivo Protects Babies From the Inside Out

Evolve BioSystems, Inc. announces the introduction of Evivo, the first and only probiotic clinically proven to restore a baby's gut microbiome to its original, natural state. Once daily Evivo helps develop a healthy immune system and metabolism to set up babies for healthier lives.